Naestved Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Naestved Denmark (1817)

Organization Overview

First Clinical Trial
2009
NCT00888511
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Daniel Hägi-Pedersen | Department of Anaesthesiology, Næstved Hospital | Naestved Hospital | Naestved Hospital, Department of Anaesthesiology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 4)

Aneurysm (Phase 2)

Aortic Aneurysm (Phase 2)

Aortic Aneurysm, Abdominal (Phase 2)

Arterial Occlusive Diseases (Phase 2)

Atherosclerosis (Phase 2)

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Joint Diseases (Phase 4)

Lung Neoplasms (Phase 2)

Pain, Postoperative (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 15